Intermacromolecular interactions with Eudragit® copolymers as a new principle of the microparticulate oral drug delivery systems development
- Authors: Moustafine RI1
-
Affiliations:
- Kazan State Medical University
- Issue: Vol 97, No 1 (2016)
- Pages: 142-147
- Section: To the 40th anniversary of Pharmaceutical Faculty of Kazan State Medical University
- URL: https://kazanmedjournal.ru/kazanmedj/article/view/2381
- DOI: https://doi.org/10.17750/KMJ2016-142
- ID: 2381
Cite item
Full Text
Abstract
The main trends of combining the chemically complementary types of (meth)acrylic copolymers of pharmaceutical-grade - Eudragit® in oral microparticulate systems with modified release (spheres, granules, capsules, etc.) - and the technological methods used in their manufacture, including various types of coating (single-layer, multi-layered, combined) are considered. It is noted that the processes that control the drugs release are based on pH-dependent intermacromolecular interaction of reactive groups between a pair of opposite charged Eudragit® copolymers both inside of spherical micro-matrix and inside the multilayer and combined coatings, allowing regulating both the degree and time of active pharmaceutical ingredients (API) release from pharmaceutical form. Using this principle allows to develop time-sensitive and pH-sensitive systems with a targeted API delivery to predetermined parts of the gastrointestinal tract, preferably to the colon, which is not only the optimal zone for absorption of many API, but also often requires treatment of inflammatory diseases of different origin. Analysis of these processes is of key importance to a better understanding of the mechanisms underlying the API transport from considered systems types, methods of their correction, modification of macromolecular parameters (such as the copolymer units charge density, the stoichiometry of the produced composition, the hydrophilic and hydrophobic fragments ratio in the polycomplexes structure affecting the swelling and resulting permeability of the system), as well as perspectives of (meth)acrylate polycomplexes use as a new class of carriers in the design of modern self-regulating, depending on the gastrointestinal tract physiological fluids pH, microparticulate oral API delivery systems.
About the authors
R I Moustafine
Kazan State Medical University
Author for correspondence.
Email: mustaf@rambler.ru
References
- Adeyeye M.C., Mwangi E., Katondo B. et al. Dissolution stability studies of suspensions of prolonged-release diclofenac microparticles prepared by Wurster process: I. Eudragit-based formulation and possible drug-excipient interaction. J. Microencapsul. 2005; 22 (4): 333-342. http://dx.doi.org/10.1080/02652040500100600
- Akhgari A., Sadeghi F., Garekani H.A. Combination of time-dependent and pH-dependent polymethacrylates as a single coating formulation for colonic delivery of indomethacin pellets. Int. J. Pharm. 2006; 320: 137-142. http://dx.doi.org/10.1016/j.ijpharm.2006.05.011
- Ammar H.O., Khalil R.M. Preparation and evaluation of sustained-release solid dispersions of drugs with Eudragit polymers. Drug Dev. Ind. Pharm. 1997; 23 (11): 1043-1054. http://dx.doi.org/10.3109/03639049709150492
- Cameron C.G., McGinity J.W. Controlled-release theophylline tablet formulations containing acrylic resins. 2. Combination resin formulations. Drug Dev. Ind. Pharm. 1987; 13 (8): 1409-1427. http://dx.doi.org/10.3109/03639048709068383
- Dalmoro A., Sitenkov A.Y., Lamberti G. et al. Ultrasonic atomization and polyelectrolyte complexation to produce gastroresistant shell-core microparticles. J. Appl. Polym. Sci. 2015. http://dx.doi.org/10.1002/app.42976
- Dittgen M., Durrani M., Lehmann K. Acrylic polymers. A review of pharmaceutical applications. STP Pharma Sci. 1997; 7: 403-437.
- Evonik Pharma Polymers. Eudragit® Application Guidelines. 12th Edition, Evonik Pharma Polymers, Darmstadt. 2013; 44-111.
- Gallardo D., Skalsky B., Kleinebudde P. Controlled release solid dosage forms using combinations of (meth)acrylate copolymers. Pharm. Dev. Technol. 2008; 13 (5): 413-423. http://dx.doi.org/10.1080/10837450802202098
- Gupta V.K., Assumus M.W., Beckert T.E., Price J.C. A novel pH- and time-based multi-unit potential colonic drug delivery system. II. Optimization of multiple response variables. Int. J. Pharm. 2001; 213: 93-102. http://dx.doi.org/10.1016/S0378-5173(00)00650-5
- Gupta V.K., Beckert T.E., Deusch N.J. et al. Investigation of potential ionic interactions between anionic and cationic polymethacrylates of multiple coatings of novel colonic delivery system. Drug Dev. Ind. Pharm. 2002; 28 (2): 207-215. http://dx.doi.org/10.1081/DDC-120002454
- Gupta V.K., Beckert T.E., Price J.C. A novel pH- and time-based multi-unit potential colonic drug delivery system. I. Development. Int. J. Pharm. 2001; 213: 83-91. http://dx.doi.org/10.1016/S0378-5173(00)00649-9
- Ichikawa H., Fukumori Y., Adeyeye M.C. Design of prolonged-release microcapsules containing diclofenac sodium for oral suspensions and their preparation by the Wurster process. Int. J. Pharm. 1997; 156: 39-48. http://dx.doi.org/10.1016/S0378-5173(97)00175-0
- Kadam V.D., Gattani S.G. Formulation and evaluation of pulsatile drug delivery system using time- and pH-dependent polymers. Pharm. Dev. Technol. 2010; 15 (1): 64-70. http://dx.doi.org/10.3109/10837450902980254
- Katsuma M., Watanabe S., Takemura S. et al. Scintigraphic evaluation of a novel colon-targeted delivery system (CODESTM) in healthy volunteers. J. Pharm. Sci. 2004; 93 (5): 1287-1299. http://dx.doi.org/10.1002/jps.20063
- Kiliçarslan M., Baykara T. Effects of the permeability characteristics of different polymethacrylates on the pharmaceutical characteristics of verapamil hydrochloride-loaded microspheres. J. Microencapsul. 2004; 21 (2): 175-189. http://dx.doi.org/10.1080/02652040310001637820
- Kim T-W., San H., Lee B-J. Characterization of dual layered pellets for sustained release of poorly water-soluble drug. Chem. Pharm. Bull. 2007; 55 (7): 975-979. http://dx.doi.org/10.1248/cpb.55.975
- Kislalioglu M.S., Khan M.A., Blount C. et al. Physical characterization and dissolution properties of ibuprofen: Eudragit coprecipitaties. J. Pharm. Sci. 1991; 80 (8): 799-804. http://dx.doi.org/10.1002/jps.2600800820
- Lorenzo-Lamoza M.L., Cuña M., Vila-Jato J.L. et al. Development of a microencapsulated form of cefuroxime axetil using pH-sensitive acrylic polymers. J. Microencapsul. 1997; 14 (5): 607-616. http://dx.doi.org/10.3109/02652049709006813
- Ly J., Wu X.Y. Bimodal release of theophylline from «seed-matrix» beads made of acrylic polymers. Pharm. Dev. Technol. 1999; 4 (2): 257-267. http://dx.doi.org/10.1081/PDT-100101360
- Moustafine R.I. Role of macromolecular interactions of pharmaceutically acceptable polymers in functioning oral drug delivery systems. Russ. J. General Chem. 2014; 84 (2): 364-367. http://dx.doi.org/10.1134/S1070363214020388
- Moustafine R.I., Bodrov A.V., Kemenova V.A. et al. Drug release modification by interpolymer interaction between countercharged types of Eudragit® RL 30D and FS 30D in double-layer films. Int. J. Pharm. 2012; 439: 17-21. http://dx.doi.org/10.1016/j.ijpharm.2012.09.044
- Mustafin R.I. Interpolymer combinations of chemically complementary grades of Eudragit® copolymers: a new direction in the design of peroral solid dosage forms of drug delivery systems with controlled release (review). Pharm. Chem. J. 2011; 45 (5): 285-295. http://dx.doi.org/10.1007/s11094-011-0618-7
- Piao Z.-Z., Lee M.-K., Lee B.-J. Colonic release and reduced intestinal tissue damage of coated tablets containing naproxen inclusion complex. Int. J. Pharm. 2008; 350: 205-211. http://dx.doi.org/10.1016/j.ijpharm.2007.08.044
- Siepmann F., Siepmann J., Walther M. et al. Polymer blends for controlled release coatings. J. Control. Rel. 2008; 125: 1-15. http://dx.doi.org/10.1016/j.jconrel.2007.09.012
- Skalsky B. Film coating of solid dosage forms: Products, applications, methods - A review. PZ Prisma. 2007; 14 (3): 149-158.
- Skalsky B., Petereit H.-U. In: Aqueous polymeric coatings for pharmaceutical dosage forms. J.W. McGinity, L.A. Felton eds. New York: Informa Healthcare. 2008; 237-279.
- Vasilevska V., Djurić K., Jovanović Z., Simov A. Preparation and dissolution characteristics of controlled release diltiazem pellets. Drug Dev. Ind. Pharm. 1992; 18 (15): 1649-1661. http://dx.doi.org/10.3109/03639049209040892
- Wu C.B., McGinity J.W. Influence of an enteric polymer on drug release rates of theophylline from pellets coated with Eudragit® RS 30D. Pharm. Dev. Technol. 2003; 8 (1): 103-110. http://dx.doi.org/10.1081/PDT-120017529
- Wulff R., Leopold C.S. Coatings from blends of Eudragit® RL and L55: A novel approach in pH-controlling drug release. Int. J. Pharm. 2014; 476: 78-87. http://dx.doi.org/10.1016/j.ijpharm.2014.09.023
- Wulff R., Leopold C.S. Coatings of Eudragit® RL and L-55 Blends: Investigations on the Drug Release Mechanism. AAPS PharmSciTech. 2015. http://dx.doi.org/10.1208/s12249-015-0377-y